The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Matthew Sacchet, Ph.D., Director of the Meditation Research Program at Massachusetts General Hospital and an Associate ...

Zymeworks' financial stability is evident with $76.3 million in revenue in 2024 and a cash runway extending through late 2027 ...

The poster will be available on SELLAS websites following the session.

Technology is reshaping healthcare in India, creating new opportunities for those interested in careers at the intersection ...

Bhavya Kadiyala is a Business Intelligence Specialist at Parkland Health and Hospital System in Dallas, Texas. With over nine ...

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

“While there’s still a lot to learn, these findings show that regular intensity exercise, even at low intensity, could go a ...

New partnership will expand access to community-based care for Medicaid members in Richmond and Hampton Roads communities ...

MAGIC-I, the country's first clinical study of genomics approaches in cancer care, is set to revolutionise childhood cancer ...

National Science Foundation funding helped Suchi Saria develop and launch a lifesaving early warning system that uses ...